ArticleOncoTargets and therapy2019

Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway.

Tao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.